oxandrolone
Conditions | Yield |
---|---|
Stage #1: 17-β-hydroxy-17-α-methyl-1-oxo-1,2-seco-A-nor-5-α-androstan-2-oic acid With sodium hydroxide In ethanol; water at 8 - 9℃; Inert atmosphere; Stage #2: With sodium tetrahydroborate In ethanol; water at 5 - 7℃; for 1h; Stage #3: With hydrogenchloride In ethanol; water at 1 - 9℃; for 8.75h; | 94% |
(4aS,4bS,6aS,7S,9aS,9bR,11aS)-7-(methoxymethoxy)-4a,6a,7-trimethyltetradeca-hydroindeno[4,5-h]isochromen-2(1H)-one
oxandrolone
Conditions | Yield |
---|---|
With 1-thiopropane; zinc dibromide In dichloromethane at 20℃; for 0.116667h; Inert atmosphere; | 91% |
oxandrolone
Conditions | Yield |
---|---|
With potassium hydroxide In methanol; water at 50℃; for 3h; | 0.06 g |
Conditions | Yield |
---|---|
Multi-step reaction with 4 steps 1: 90 percent / pyridine / 20 °C 2: 85 percent / Candida antarctica B lipase / ethanol / 3 h / 30 °C 3: Jones reagent / acetone 4: 0.06 g / KOH / methanol; H2O / 3 h / 50 °C View Scheme |
17β-hydroxy-17α-methyl-1,3-seco-2-nor-5α-androstane-1,3-diacid 1,3-dimethylester
oxandrolone
Conditions | Yield |
---|---|
Multi-step reaction with 5 steps 1: 95 percent / LiAlH4 / tetrahydrofuran / 2 h / 20 °C 2: 90 percent / pyridine / 20 °C 3: 85 percent / Candida antarctica B lipase / ethanol / 3 h / 30 °C 4: Jones reagent / acetone 5: 0.06 g / KOH / methanol; H2O / 3 h / 50 °C View Scheme |
(3S,3aS,5aS,6S,7S,9aS,9bS)-7-Carboxymethyl-3-hydroxy-3,3a,6-trimethyl-dodecahydro-cyclopenta[a]naphthalene-6-carboxylic acid
oxandrolone
Conditions | Yield |
---|---|
Multi-step reaction with 6 steps 1: methanol; diethyl ether 2: 95 percent / LiAlH4 / tetrahydrofuran / 2 h / 20 °C 3: 90 percent / pyridine / 20 °C 4: 85 percent / Candida antarctica B lipase / ethanol / 3 h / 30 °C 5: Jones reagent / acetone 6: 0.06 g / KOH / methanol; H2O / 3 h / 50 °C View Scheme |
Acetic acid (3S,3aS,5aS,6S,7S,9aR,9bS)-3-hydroxy-7-(2-hydroxy-ethyl)-3,3a,6-trimethyl-dodecahydro-cyclopenta[a]naphthalen-6-ylmethyl ester
oxandrolone
Conditions | Yield |
---|---|
Multi-step reaction with 2 steps 1: Jones reagent / acetone 2: 0.06 g / KOH / methanol; H2O / 3 h / 50 °C View Scheme |
Conditions | Yield |
---|---|
Multi-step reaction with 3 steps 1: 85 percent / Candida antarctica B lipase / ethanol / 3 h / 30 °C 2: Jones reagent / acetone 3: 0.06 g / KOH / methanol; H2O / 3 h / 50 °C View Scheme |
17β-hydroxy-17α-methyl-2-oxa-5α-androstane-1,3-dione
oxandrolone
Conditions | Yield |
---|---|
With sodium borohydrid; sulfuric acid In water; N,N-dimethyl-formamide | 6.1 g (75.2%) |
Conditions | Yield |
---|---|
Multi-step reaction with 4 steps 1.1: pyridinium hydrobromide perbromide / ethanol; water / 5.25 h / 24 - 27 °C / Inert atmosphere; Large scale 2.1: lithium carbonate; lithium bromide / N,N-dimethyl-formamide / 3 h / 110 - 115 °C / Inert atmosphere 3.1: ozone / methanol / 6 h / -40 - -30 °C / Inert atmosphere; Large scale 4.1: sodium hydroxide / ethanol; water / 8 - 9 °C / Inert atmosphere 4.2: 1 h / 5 - 7 °C 4.3: 8.75 h / 1 - 9 °C View Scheme |
2α-bromo-17β-hydroxy-17α-methyl-5α-androstan-3-one
oxandrolone
Conditions | Yield |
---|---|
Multi-step reaction with 3 steps 1.1: lithium carbonate; lithium bromide / N,N-dimethyl-formamide / 3 h / 110 - 115 °C / Inert atmosphere 2.1: ozone / methanol / 6 h / -40 - -30 °C / Inert atmosphere; Large scale 3.1: sodium hydroxide / ethanol; water / 8 - 9 °C / Inert atmosphere 3.2: 1 h / 5 - 7 °C 3.3: 8.75 h / 1 - 9 °C View Scheme |
5α-17β-hydroxy-17α-methyl-Δ1-androsten-3-one
oxandrolone
Conditions | Yield |
---|---|
Multi-step reaction with 2 steps 1.1: ozone / methanol / 6 h / -40 - -30 °C / Inert atmosphere; Large scale 2.1: sodium hydroxide / ethanol; water / 8 - 9 °C / Inert atmosphere 2.2: 1 h / 5 - 7 °C 2.3: 8.75 h / 1 - 9 °C View Scheme |
oxandrolone
17,17-dimethyl-18-nor-2-oxa-5α-androst-13(14)-en-3-one
Conditions | Yield |
---|---|
With hydrogenchloride for 0.25h; Ambient temperature; | 73% |
oxandrolone
Conditions | Yield |
---|---|
With water; sodium hydroxide In methanol at 20℃; for 0.25h; Inert atmosphere; | 52% |
oxandrolone
A
6α-hydroxyoxandrolone
B
11α-hydroxyoxandrolone
C
9α-hydroxyoxandrolone
Conditions | Yield |
---|---|
With potassium dihydrogenphosphate; D-glucose; sodium chloride; peptone; yeast extract In water; acetone at 28℃; for 240h; | A 5% B 25% C 8% |
Conditions | Yield |
---|---|
With chlorosulfonic acid 1.) -5 deg C, 2.) RT, 3 h; Yield given. Multistep reaction; |
oxandrolone
Sulfuric acid mono-((5S,8R,9S,10S,13S,14S,17S)-10,13,17-trimethyl-3-oxo-hexadecahydro-2-oxa-cyclopenta[a]phenanthren-17-yl) ester
Conditions | Yield |
---|---|
With sulfur trioxide pyridine complex In N,N-dimethyl-formamide for 2h; Ambient temperature; |
oxandrolone
17α-hydroxy-17β-methyl-2-oxa-5α-androstan-3-one
Conditions | Yield |
---|---|
Multi-step reaction with 2 steps 1: sulfur trioxide pyridine complex / dimethylformamide / 2 h / Ambient temperature 2: H2O / 12 h View Scheme |
oxandrolone
(5S,8R,9S,10S,13S,14S,17R)-10,13,17-Trimethyl-17-trimethylsilanyloxy-tetradecahydro-2-oxa-cyclopenta[a]phenanthren-3-one
Conditions | Yield |
---|---|
Multi-step reaction with 3 steps 1: sulfur trioxide pyridine complex / dimethylformamide / 2 h / Ambient temperature 2: H2O / 12 h 3: trimethylsilylimidazole / 0.17 h / 60 °C View Scheme |
oxandrolone
Conditions | Yield |
---|---|
Multi-step reaction with 4 steps 1: sulfur trioxide pyridine complex / dimethylformamide / 2 h / Ambient temperature 2: H2O / 12 h 3: trimethylsilylimidazole / 0.17 h / 60 °C 4: trimethyliodosilane / 0.25 h / 60 °C View Scheme |
chloromethyl methyl ether
oxandrolone
(4aS,4bS,6aS,7S,9aS,9bR,11aS)-7-(methoxymethoxy)-4a,6a,7-trimethyltetradeca-hydroindeno[4,5-h]isochromen-2(1H)-one
Conditions | Yield |
---|---|
With N-ethyl-N,N-diisopropylamine In dichloromethane at 0 - 60℃; Inert atmosphere; |
N-methyl-N-trimethylsilyl-2,2,2-trifluoroacetamide
oxandrolone
C22H38O3Si
Conditions | Yield |
---|---|
With ammonium iodide; 2-hydroxyethanethiol at 60℃; for 0.333333h; |
oxandrolone
Conditions | Yield |
---|---|
With culture medium of Macrophomina phaseolina In methanol at 26℃; for 456h; Microbiological reaction; | A 10 mg B 15 mg C 30 mg D 25 mg |
oxandrolone
Conditions | Yield |
---|---|
With culture of Cunninghamella blakesleeana In methanol at 26℃; for 432h; Microbiological reaction; | 8 mg |
Conditions | Yield |
---|---|
With pyridine; trichlorophosphate at 50℃; for 1.5h; |
oxandrolone
Conditions | Yield |
---|---|
Stage #1: oxandrolone With pyridine; trichlorophosphate at 50℃; for 1.5h; Stage #2: With 3-chloro-benzenecarboperoxoic acid In aq. phosphate buffer; chloroform at 20℃; for 3h; | A 56 mg B n/a C n/a |
Conditions | Yield |
---|---|
Stage #1: oxandrolone With pyridine; trichlorophosphate at 50℃; for 1.5h; Stage #2: With 3-chloro-benzenecarboperoxoic acid In aq. phosphate buffer; chloroform at 20℃; for 3h; Stage #3: With acetic acid at 20℃; for 24h; | A 145 mg B n/a |
Oxandrolone is one kind of white or almost white crystalline powder. The IUPAC name of this chemical is (1S,3aS,3bR,5aS,9aS,9bS,11aS)-1-hydroxy-1,9a,11a-trimethyl-2,3,3a,3b,4,5,5a,6,9,9b,10,11-dodecahydroindeno[4,5-h]isochromen-7-one. The product's categories are miscellaneous; biochemistry; steroids. Additionally, Oxandrolone is toxic and flammable. This chemical is odorless and white crystalline powder which is soluble in chloroform, slightly soluble in ethanol, acetone, ether, and very slightly soluble in water. Besides, the Classification Code of Oxandrolone is Anabolic Agents; Androgen; Androgens; Hormone; Hormones; Hormones, Hormone Substitutes, and Hormone Antagonists; Reproductive Effect. The Oxandrolone is male hormone with the major role protein assimilation. It is used in the treatment of high cholesterol and triglyceride disorders. It will produce irritative smoke when buring. So the storage environment should be ventilate, low-temperature and dry. Furthermore, Oxandrolone can be obtained by 5-androstane-1-en-3-17-dione or 17β-Hydroxy-17-α-methyl derivatives.
Physical properties about Oxandrolone are:
(1)ACD/LogP: 3.33; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): 3.33; (4)ACD/LogD (pH 7.4): 3.33; (5)ACD/BCF (pH 5.5): 199.84; (6)ACD/BCF (pH 7.4): 199.84; (7)ACD/KOC (pH 5.5): 1543.23; (8)ACD/KOC (pH 7.4): 1543.23; (9)#H bond acceptors: 3; (10)#H bond donors: 1; (11)#Freely Rotating Bonds: 1; (12)Index of Refraction: 1.526; (13)Molar Refractivity: 85.1 cm3; (14)Molar Volume: 277 cm3; (15)Polarizability: 33.73×10-24 cm3; (16)Surface Tension: 39.8 dyne/cm; (17)Enthalpy of Vaporization: 81.03 kJ/mol; (18)Vapour Pressure: 9.19E-10 mmHg at 25°C; (19)Tautomer Count: 2; (20)Exact Mass: 306.219495; (21)MonoIsotopic Mass: 306.219495; (22)Topological Polar Surface Area: 46.5; (23)Heavy Atom Count: 22; (24)Complexity: 503.
People can use the following data to convert to the molecule structure.
(1)SMILES:O=C3OC[C@@]2([C@H]1CC[C@@]4(C)[C@H]([C@@H]1CC[C@H]2C3)CC[C@@]4(O)C)C;
(2)Std. InChI:InChI=1S/C19H30O3/c1-17-11-22-16(20)10-12(17)4-5-13-14(17)6-8-18(2)15(13)7-9-19(18,3)21/h12-15,21H,4-11H2,1-3H3/t12-,13+,14-,15-,17-,18-,19-/m0/s1;
(3)Std. InChIKey:QSLJIVKCVHQPLV-PEMPUTJUSA-N.
The following are the toxicity of Oxandrolone:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
man | TDLo | oral | 2400ug/kg/2W- (2.4mg/kg) | BEHAVIORAL: EUPHORIA BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) BEHAVIORAL: IRRITABILITY | Journal of Clinical Psychiatry. Vol. 46, Pg. 354, 1985. |
mouse | LD50 | intraperitoneal | 922mg/kg (922mg/kg) | SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 65, Pg. 418, 1969. |
mouse | LD50 | oral | 1832mg/kg (1832mg/kg) | SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 65, Pg. 418, 1969. |
mouse | LD50 | subcutaneous | > 11gm/kg (11000mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 65, Pg. 418, 1969. |
rabbit | LD50 | oral | > 5gm/kg (5000mg/kg) | Drugs in Japan Vol. 6, Pg. 149, 1982. | |
rat | LD50 | intraperitoneal | 4893mg/kg (4893mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: TREMOR | Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 65, Pg. 418, 1969. |
rat | LD50 | oral | > 10gm/kg (10000mg/kg) | Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 65, Pg. 418, 1969. | |
rat | LD50 | subcutaneous | > 10gm/kg (10000mg/kg) | Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 65, Pg. 418, 1969. |
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View